Similar Stories 🔰

A study reveals how digitally unified insurance systems can transform India's healthcare, enhancing access, transparency, and efficiency.

A new WHO report shows malaria cases jumped to 282 million in 2024, driven by drug resistance, weak health systems and funding gaps, with Africa and India facing the heaviest burden.

Loneliness is now a global health risk, with WHO comparing its impact to smoking. Sadhguru says meditation and even 10 minutes of silence can help reconnect the mind and ease inner distress.

WHO issues a global guideline on the use of GLP-1 medicines in treating obesity

The WHO has officially recommended GLP-1 drugs, such as semaglutide, for treating obesity in adults at high risk of weight-related complications. Citing strong evidence for significant weight loss and improved health outcomes, the agency says these medications should be used alongside lifestyle changes. The guidance marks a major shift in global obesity care. , Health, Times Now

WHO endorses GLP-1 drugs for obesity treatment, emphasizing diet and exercise while advocating for equitable access worldwide.

With December 3 marking the International Day of Persons with disabilities, the World Health Organisation (WHO), this year, focuses on inclusive financing to cr

WHO's new guidance supports Ozempic-class GLP-1 drugs for obesity treatment, but only alongside behavioural therapy and long-term care, stressing safety concerns, high costs, and the urgent need for equitable global access., Health, Times Now

WHO has issued its first global guideline supporting the use of GLP-1 weight-loss medicines for long-term obesity care, calling obesity a chronic disease and urging lifelong treatment with medical and lifestyle support.

The WHO has released new guidelines on GLP-1 therapies for obesity, emphasising long-term care, lifestyle changes, and global access to treatments.